Department of Health and Social Care (DHSC) has issued a medicine supply notification for Permethrin 5% w/w cream. MSN/2023/083 Tier 2 – medium impact Date of issue 8th September 2023 Permethrin 5% w/w cream is in limited supply until further notice due to an increase in demand. Unlicensed supplies of permethrin 5% cream may be
Read moreClass 4 Medicines Defect Information: Duraphat 5000ppm Fluoride Toothpaste (51g) Colgate-Palmolive (U.K.) Limited Drug alert number: EL (23)A/35 Date issued: 7 September 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Duraphat 5000ppm Fluoride Toothpaste (51g) Colgate-Palmolive (U.K.) Limited Company name: Colgate-Palmolive (U.K.) Limited Product
Read moreThe Government has updated their guidance on the HRT PPC. Some of the key changes include: Clarifying that listed HRT medicines, regardless of the clinical reason for prescribing, must be on a separate prescription to other non-HRT items, on both paper and electronic prescriptions. Explaining the scope of the HRT PPCs, highlighting that the PPC
Read morePeter Aldous MP has secured a Westminster Hall Debate on the Future of Community Pharmacies, on Thursday 14th September at 3pm. This is very timely as it will coincide with the launch of the Vision for community pharmacy on the 19th September, which is being developed by The King’s Fund and Nuffield Trust. This will
Read moreDrug alert number: EL (23)A/34 Date issued: 5 September 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Evorel Sequi (Theramex HQ UK Ltd) PL 49105/0010 SNOMED Code: 3217311000001104 Batch Number Expiry Date Pack Size First Distributed 6029403 July 2024 8 patches 13th June 2023 Active Pharmaceutical
Read moreThe UK Health Security Agency (UKHSA) and the Met Office have issued an amber alert for all of England except for the North East, which was placed under a yellow alert. The amber alert indicates that the impact of the heat is expected to be felt by the wider population and will have an impact
Read moreBy Chief Executive Janet Morrison As we move into September thoughts inevitably turn to the coming winter, and it’s hard to be optimistic when all signs suggest that this will be one of the most challenging yet for community pharmacies and the wider NHS. As doctors continue to strike – despite ongoing assurances from
Read moreThis summer the Government announced the Windsor Framework, which sets out the long-term arrangements for the supply of medicines into Northern Ireland. It will ensure that medicines can be approved and licensed on a UK-wide basis by the Medicines and Healthcare products Regulatory Agency (MHRA) and provides for the disapplication of European Union (EU) Falsified
Read moreClass 4 Medicines Defect Information:Tostran (Testosterone 2% gel) (Kyowa Kirin Limited) Drug alert number: EL (23)A/33 Date issued: 31 August 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Tostran (Testosterone 2% gel), Kyowa Kirin Limited Company name: Galderma (U.K.) Limited Product name: LTostran (Testosterone
Read moreA new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 1 August 2023) has been published and includes articles on: Fluoroquinolone antibiotics: reminder of the risk of disabling and potentially long-lasting or irreversible side effects Methotrexate: advise patients to take precautions in the sun to avoid photosensitivity reactions Valproate: re-analysis
Read more
